GlassScriptPhysician profile
Naila D Avery
NPI 1700036613
$1,597.18
in general payments reported to CMS, 2019-2025
23 companies · $38.35 in 2025
The $38.35 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $129 · 2021: $78.77 · 2022: $568 · 2023: $288 · 2024: $366 · 2025: $38.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.06 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $407.90 | 2022-2024 | |
| Polynovo North America LLC | $262.93 | 2021-2024 | Novosorb Btm |
| Teleflex LLC | $147.11 | 2019-2023 | Quikclot |
| Lexington Medical, INC. | $106.81 | 2022 | |
| Baxter Healthcare | $95.93 | 2021-2024 | Perclot, Seprafilm |
| Prytime Medical Devices, INC. | $84.82 | 2024 | Er-Reboa Plus |
| Portola Pharmaceuticals, LLC | $76.72 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $70.64 | 2020-2022 | |
| Ethicon US, LLC | $44.68 | 2020 | |
| Integra Lifesciences Corporation | $40.90 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Z-Medica, LLC | $40.45 | 2019 | |
| Biom'Up Sa | $23.03 | 2019 | |
| Octapharma USA, INC. | $22.93 | 2025 | Fibryga |
| Biom'Up France Sas | $21.92 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.49 | 2023 | Andexxa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.00 | 2024 | Kcentra |
| Medline Industries LP | $18.76 | 2020 | |
| Kerecis Limited | $18.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Innocoll Pharmaceuticals Limited | $18.56 | 2022 | |
| Convatec INC. | $15.95 | 2022 | |
| Smith+Nephew, INC. | $15.42 | 2025 | Grafix Pl, Stravix |
| Takeda Pharmaceuticals U.S.A., INC. | $13.50 | 2022 | |
| Reprise Biomedical, INC. | $9.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naila Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.